COG2 and familial hypercholesterolemia: Human genetic evidence has increasingly been reported as a predictor for the success of drugs in clinical trials [55], and consistent with this, we demonstrate that LDL-C GWAS hits are highly enriched for a set of known causal genes for hypercholesterolemia, over 527-fold compared to what is expected by chance.